Fresenius Medical Care: A 'Buy' Going Into 2025
Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a solid “Buy” opportunity.
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Kepler Capital
Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on January 31 and set a ...
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from UBS
UBS analyst Graham Doyle maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) today and set a price target of ...